Janet Woodcock Podcasts
Last Updated: Feb 8th, 2022
The 8 Best Janet Woodcock Podcasts
1) Interview with Dr. Janet Woodcock
Dr. Freire engages in a lively and eye-opening conversation with Dr. Janet Woodcock, acting commissioner of the Food and Drug Administration. Drs. Freire and Woodcock explore the process to move drug ...Show More
2) Episode 2 - Interview with Janet Woodcock, Principal Deputy Commissioner of the FDA
Host Jim Fries speaks to Dr. Janet Woodcock, Principal Deputy Commissioner of the FDA, in the second episode of The Patient Safety Podcast. Originally recorded on January 19th, 2022 when Dr. Janet Woo...Show More
Episode 2 - Interview with Janet Woodcock, Principal Deputy Commissioner of the FDA
21:28 | Feb 24th, 2022
3) Operating at “Warp Speed” with Dr. Janet Woodcock
Operation Warp Speed’s Therapeutics lead Dr. Janet Woodcock on therapies in development, how to interpret pauses in vaccine trials, and why the vast majority of drug trials don’t yield actionable info...Show More
4) The FDA Commissioner on Boosters & Vaccines for Kids (with Dr. Janet Woodcock)
As we await the FDA’s final decision on booster shots, Andy talks with the person tasked with making the final determination: Acting FDA Commissioner Dr. Janet Woodcock. Only on In the Bubble wi...Show More
The FDA Commissioner on Boosters & Vaccines for Kids (with Dr. Janet Woodcock)
37:39 | Sep 20th, 2021
5) Navigating FDA’s Future: Janet Woodcock on the Evolving Regulatory Landscape
Shelly and Wayne chat with Janet Woodcock, M.D., former FDA Principal Deputy Commissioner. Woodcock shares her expert insights on the agency’s approach to navigating the current regulatory environment...Show More
6) Conviction and Courage: Dr. Janet Woodcock on Leading Through Change
Dr. Janet Woodcock didn’t set out to become a federal leader—but over the course of more than three decades at the Food and Drug Administration, she helped transform the agency from within. As former ...Show More
7) Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials
Guest: Janet, Woodcock, MD, Director, CDER, FDA Bio and Contact Info Listen (4:41) No agency charged with better translational outcomes
Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials
0:00 | Nov 13th, 2014
8) Drug Fix: Janet Woodcock retiring, Accelerated Approval Reform, US FDA Meeting Recording Policy
Pink Sheet reporters and editors discuss US FDA Principal Deputy Commissioner Janet Woodcock’s legacy as her retirement approaches (:42), the stance of the FDA’s oncology division on confirming benefi...Show More
Similar Celebrities to Janet Woodcock
What do you think of this page?